Keyphrases
Renal Function
100%
Gemfibrozil
100%
Coronary Disease
100%
Chronic Renal Insufficiency
100%
High-density Lipoprotein Cholesterol (HDL-C)
55%
Kidney Function
44%
Clinically Significant
33%
Placebo
22%
Loss Function
22%
Estimated Glomerular Filtration Rate
22%
Serum Creatinine Level
22%
Intervention Studies
11%
Myocytes
11%
Triglycerides
11%
Subgroup Analysis
11%
Randomized Double-blind Trial
11%
Lipid Levels
11%
Renal Function Decline
11%
Low-density Lipoprotein Cholesterol (LDL-C)
11%
Potential Confounders
11%
Rate of Change
11%
Confidence Interval
11%
Veterans Affairs
11%
Triglyceride Level
11%
Metabolic Syndrome Components
11%
Decline Rate
11%
Multivariate Regression
11%
Rapid Rate
11%
Fibric Acid Derivatives
11%
Reduced Rate
11%
Serum Creatine Kinase
11%
Triglyceride-rich Lipoproteins
11%
Diabetes Distress
11%
Low-density Lipoprotein Cholesterol Level
11%
Placebo Groups
11%
Medicine and Dentistry
Chronic Kidney Disease
100%
Kidney Function
100%
Coronary Artery Disease
100%
Gemfibrozil
100%
High Density Lipoprotein Cholesterol
40%
Placebo
30%
Glomerular Filtration Rate
20%
Creatinine
20%
Triacylglycerol
20%
Study Subject
10%
Subgroup Analysis
10%
Metabolic Syndrome
10%
Diabetes Mellitus
10%
Veterans Affairs
10%
High-Density Lipoprotein
10%
Intervention Trial
10%
Low Density Lipoprotein Cholesterol
10%
Creatine Kinase
10%
Triglyceride-Rich Lipoprotein
10%
Nursing and Health Professions
Chronic Kidney Failure
100%
Coronary Artery Disease
100%
Gemfibrozil
100%
High Density Lipoprotein Cholesterol Level
33%
Placebo
33%
Creatinine Blood Level
22%
Estimated Glomerular Filtration Rate
22%
Triacylglycerol
22%
Metabolic Syndrome X
11%
Triacylglycerol Level
11%
Lipoprotein
11%
Lipid Level
11%
Creatine Kinase Blood Level
11%
Low Density Lipoprotein Cholesterol Level
11%
High Density Lipoprotein
11%
Study Subject
11%
Fibric Acid Derivative
11%
Confidence Interval
11%
High Density Lipoprotein Cholesterol
11%
Diabetes Mellitus
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Coronary Artery Disease
100%
Gemfibrozil
100%
High Density Lipoprotein Cholesterol
44%
Placebo
33%
Triacylglycerol
33%
Creatinine
22%
Intervention Trial
11%
Metabolic Syndrome X
11%
Lipoprotein
11%
Low Density Lipoprotein Cholesterol
11%
Fibric Acid Derivative
11%
High Density Lipoprotein
11%
Diabetes Mellitus
11%
Creatine Kinase
11%
Biochemistry, Genetics and Molecular Biology
Gemfibrozil
100%
Kidney Function
100%
Coronary Artery Disease
100%
High Density Lipoprotein Cholesterol Level
30%
Glomerulus Filtration
20%
Creatinine Blood Level
20%
Triglyceride
10%
Triglyceride-Rich Lipoprotein
10%
Intervention Trial
10%
HDL-Cholesterol
10%
Triacylglycerol Level
10%
Lipid Level
10%
Low Density Lipoprotein Cholesterol Level
10%
Creatine Kinase Blood Level
10%
High-Density Lipoprotein
10%